Titan Pharmaceuticals Inc (TTNP) USD0.001

Sell:$3.70Buy:$4.15$0.09 (2.37%)

Prices delayed by at least 15 minutes
Sell:$3.70
Buy:$4.15
Change:$0.09 (2.37%)
Deal now
Prices delayed by at least 15 minutes
Sell:$3.70
Buy:$4.15
Change:$0.09 (2.37%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Titan Pharmaceuticals, Inc. is a pharmaceutical company. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus, and Nalmefene Implant, which is for the prevention of relapse in OUD patients following detoxification from opioids Its product development programs are in non-clinical stages of development.

Key people

Weei Jye Chay
Chief Executive Officer
Brynner Chiam
Acting Principal Financial Officer, Director
Avraham Ben-Tzvi
Independent Director
Firdauz Edmin Bin Mokhtar
Independent Director
Francisco Osvaldo Flores Garcia
Independent Director
Gabriel Loh
Independent Director
Click to see more

Key facts

  • EPIC
    TTNP
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US8883147055
  • Market cap
    $3.38m
  • Employees
    4
  • Shares in issue
    914,234.00
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.